To assess whether miR‐138 inhibits the proliferation of NSCLC cells by targeting GIT1 or SEMA4C, we first asked whether the knockdown of GIT1 or SEMA4C can impair the proliferation of NSCLC cells. The gene discussed is GIT1; the disease is non-small cell lung carcinoma.